Oral midazolam versus intranasal Dexmedetomidine for CT imaging in childre
Phase 3
Completed
- Conditions
- Health Condition 1: null- Pediatric patients visiting hospital for diagnostic CT Imaging
- Registration Number
- CTRI/2014/03/004456
- Lead Sponsor
- Post Graduate Institute of Medical Education and Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 48
Inclusion Criteria
ASA I or II children aged 1 â?? 5 years scheduled for CT imaging under sedation
Exclusion Criteria
Children with history of allergy to eutectic mixture of local anesthetic (EMLA) cream, midazolam severe dysfunction of central nervous system, malformation of cardiovascular system, children on chronic hepatic enzyme inducing drugs or mentally retarded children
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method incidence of children requiring rescue sedation (IV ketamine)Timepoint: during CT Imaging
- Secondary Outcome Measures
Name Time Method incidence of children crying at venipuncture, number of attempts at venipuncture, sedation and venipuncture scores, requirement of ketamine for CT, parental satisfaction, movements and motion artifacts during scan and requirement of repeat scanTimepoint: at venepuncture and during CT imaging